Latest Stock Split Details
Key information about Generex Biotechnology Corporation's most recent stock split
Split Date: 2020-02-25
Split Ratio: 7:5
Price Before Split: N/A
Price After Split: N/A
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.40 times more shares (a 7:5 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Generex Biotechnology Corporation's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2020-02-25 | 7:5 | No | N/A | N/A |
| 2020-01-13 | 7:5 | No | N/A | N/A |
| 2019-12-02 | 2:1 | No | N/A | N/A |
| 2019-10-31 | 2:1 | No | N/A | N/A |
| 2019-07-23 | 2:1 | No | N/A | N/A |
| 2018-12-03 | 21:1 | No | N/A | N/A |
| 2017-03-14 | 1:1000 | Yes | N/A | N/A |
About Generex Biotechnology Corporation
Company overview and industry information
Generex Biotechnology Corporation (GNBTQ) operates in the Biotechnology industry. The recent 7-for-5 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Biotechnology
Go to Generex Biotechnology Corporation Summary